PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.84%
Some net income increase while TSM is negative at -11.81%. John Neff would see a short-term edge over the struggling competitor.
-1.76%
Negative yoy D&A while TSM is 4.17%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
104.87%
Some yoy growth while TSM is negative at -120.12%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
7.13%
SBC growth of 7.13% while TSM is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-222.02%
Negative yoy working capital usage while TSM is 796.63%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
150.03%
AR growth of 150.03% while TSM is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-4655.62%
Negative yoy inventory while TSM is 6.50%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-43.20%
Both negative yoy AP, with TSM at -3083.23%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-243.12%
Negative yoy usage while TSM is 871.49%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-239.71%
Negative yoy while TSM is 83.65%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-51.00%
Negative yoy CFO while TSM is 10.34%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-36.05%
Both yoy lines negative, with TSM at -4.11%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-41.84%
Negative yoy purchasing while TSM stands at 91.77%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-34.82%
Both yoy lines are negative, with TSM at -44.08%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
100.00%
We have some outflow growth while TSM is negative at -4.18%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-197.15%
Both yoy lines negative, with TSM at -3.39%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
1.63%
Issuance growth of 1.63% while TSM is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.